ClinicalTrials.gg
RecruitingNCT05734651Updated Feb 21, 2023

PROMIS Evaluation Study

An observational study in Hip Arthropathy, Osteoarthritis, Hip and Perthes Disease, sponsored by Bezirkskrankenhaus St. Johann in Tirol. Recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-21.

Sponsored by Bezirkskrankenhaus St. Johann in Tirol · Observational

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Feb 2023; still recruiting 3 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

A total of 250 total hip arthroplasties (THA) are performed at the Bezirkskrankenhaus St. Johann. In a majority of those, implants from the company Falcon Medical (Austria) are used. Those implants are undergoing constant development and improvement. To guarantee their clinical performance, this clinical study is evaluating safety and efficacy of all implants produced by Falcon Medical.

The purpose of this study is to evaluate the effcacy and safety of implants produced and distributed by Falcon Medical. All patients with primary THA and usage of a Falcon Medical implant are included. The outcome measures include intra-operative complications, early post-operative complications, revision for any cause and patient reported outcome (WOMAC questionnaire). All data is prospectively collected in a standardized fashion.

02

Conditions studied

  • Hip Arthropathy
  • Osteoarthritis, Hip
  • Perthes Disease
  • Osteonecrosis
  • Femoral Neck Fractures
03

In context

Osteoarthritis, Hip

641 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

This study's planned enrollment of 200 is above the median of 135 across 158 observational studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

Bezirkskrankenhaus St. Johann in Tirol is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patient treated with primary total hip arthroplasty at this department are included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primary total hip arthroplasty with the PROMIS stem

Exclusion criteria

Exclusion Criteria:

  • n/a
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
20 Years
Patient registry
Yes

Groups and cohorts

  • Intervention

    Device: PROMIS Stem

Interventions

  • DevicePROMIS Stem

    Primary Total Hip Arthroplasty with the PROMIS Stem (Fa. Falcon Medical, Mödling, Austria)

06

What researchers measure

Primary outcomes

  1. Stem Migration

    Stem Migration measured with the validated EBRA method. The stem migration is assessed in millimeters. The radiograph before surgery and sequential radiographs after surgery are assessed.

    Time frame: 20 years

Secondary outcomes

  1. WOMAC Score

    Patient reported outcome score that is assessed before the surgery and one year after the surgery, 5 years after the surgery, 10 years and 20 years after the surgey.

    Time frame: 20 years

07

Study locations

1 of 1 sites recruiting
  • BKH St. Johann in Tirol, Department for Orthopedics and Traumatology
    Sankt Johann In Tirol, Tyrol 6380, Austria
    Recruiting
08

References and documents

Publications

  • Wagner M, Neururer S, Dammerer D, Nardelli P, Kaufmann G, Braito M, Brunner A. External validation of the Tyrolean hip arthroplasty registry. J Exp Orthop. 2022 Aug 30;9(1):87. doi: 10.1186/s40634-022-00526-3. PubMed 36042064 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05734651
Lead sponsor
Bezirkskrankenhaus St. Johann in Tirol
Collaborators
Tyrolean Arthroplasty Registry
Responsible party
Moritz Wagner (Principal Investigator, Bezirkskrankenhaus St. Johann in Tirol) — Principal investigator
First posted
Feb 21, 2023
Start date
Feb 9, 2023
Primary completion
Feb 9, 2026 (estimated)
Completion
Feb 9, 2042 (estimated)
Last update
Feb 21, 2023

Study contacts

Moritz Wagner, MD
Contact
moritz.wagner@khsj.at
+4350536608167
Hannes Schönthaler, MD
Contact
hannes.schönthale@khsj.at
+435356608369

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion